Dividend-adjusted return from the previous close · S&P 500 uses VOOXLVS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −2.5% | +9.5% | +12.0% | +20.9% | +29.6% | +56.1% | +51.3% | +688.9% |
| Peer average | −3.4% | +4.6% | +3.5% | +19.7% | +29.0% | +75.3% | +27.3% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $50.9B
- Expense ratio
- 0.08%
- Distribution yield
- 1.4%
- NAV
- $189.65
- Volume
- 23.9M
- Avg. volume 30D
- 10.1M
- High today
- $192.31
- Low today
- $184.82
- Previous close
- $189.66
- 52-week high
- $192.31
- 52-week low
- $141.97
- Our risk indicator
- 4/5
XLV in One Breath
XLV Among Health Care ETFs
YTDEnd-of-day Nov 6, 2026 · 33 Health care ETFs by YTD
$10,000 in XLV
5Y$10,000 in XLV became
$15,134
In the S&P 500 (VOO)
$17,156
Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO
XLV’s Top Holdings
TodayLLYEli Lilly +16.5%JNJ9.7%ABBV7.6%MRK5.4%UNH5.3%TMO3.8%AMGN3.8%GILD3.1%ABT2.9%PFE2.6%ISRG2.5%DHR2.1%VRTX2.0%BMY1.9%MDT1.9%MCK1.8%SYK1.7%CVS1.5%MRNA1.4%ELVREGNCI39 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
SPDR XLV · 61 holdings · tile size = share of the fund · as of Nov 5, 2026
What XLV Holds
TodayDrug Manufacturers - General51.1%
LLY 16.5 · JNJ 9.7 · ABBV 7.6 · MRK 5.4 · AMGN 3.8 · GILD 3.1 · PFE 2.6
Medical - Diagnostics & Research11.1%
TMO 3.8 · DHR 2.1 · IDXX · A · WAT · IQV · MTD
Medical - Healthcare Plans10.7%
UNH 5.3 · CVS 1.5 · ELV 1.4 · CI 1.2 · HUM · CNC
Medical - Devices10.0%
ABT 2.9 · MDT 1.9 · SYK 1.7 · BSX · EW · GEHC · DXCM
Biotechnology5.2%
VRTX 2.0 · MRNA 1.4 · REGN 1.3 · INCY · TECH
Medical - Instruments & Supplies4.8%
ISRG 2.5 · BDX · RMD · WST · BAX · SOLV · COO
Medical - Distribution3.8%
MCK 1.8 · COR · CAH · HSIC
SPDR XLV · share of the fund by industry · as of Nov 5, 2026
Eli’s Share of XLV
Today16.5%
$165 of every $1,000 in XLV is Eli
Eli held by XLV
$8.4B
SPDR XLV · each square = $10 of $1,000 · as of Nov 5, 2026
XLV’s Share of Health Care ETFs
Today45.4%
of the $112B in 39 Health care ETFs
$50.9B45.4%
$19.1B17.0%
$10.9B9.7%
$31.2B27.8%
Health care ETF AUM · Nov 6, 2026
XLV Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 6, 2026
Inside XLV
61 holdings · as of Nov 5, 2026XLV
State Street Health Care Select Sector SPDR ETF
TodayDrug Manufacturers - General51.1%LLYELI Lilly +16.5%JNJ9.7%ABBV7.6%MRK5.4%AMGN3.8%GILD3.1%PFEBMYBIIBMedical - Diagnostics11.1%TMO3.8%DHRIDXXAWATIQVMTDILMNMedical - Healthcare Plans10.7%UNH5.3%CVSELVCIHUMCNCMedical - Devices10.0%ABTMDTSYKBSXEWDXCMBiotechnology5.2%VRTX2.0%MRNAREGNMedical - Instruments4.8%ISRGBDXRMDWSTMedical - Distribution3.8%MCKCORCAHHCAZTSVEEVSTE
Drug Manufacturers - General51.1%LLY16.5%JNJ9.7%ABBV7.6%MRK5.4%AMGNGILD3 moreMedical - Diagnostics11.1%TMODHRIDXXAWAT6 moreMedical - Healthcare Plans10.7%UNH5.3%CVSELVCIHUMCNCMedical - Devices10.0%ABTMDTSYKBiotechnology5.2%VRTXMRNAREGNMedical - Instruments4.8%ISRGBDXMedical - Distribution3.8%MCKCORCAHHCAVEEV
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly + | 16.50% |
| 2 | JNJ | Johnson + Johnson | 9.69% |
| 3 | ABBV | Abbvie | 7.58% |
| 4 | MRK | Merck + | 5.40% |
| 5 | UNH | Unitedhealth Group | 5.34% |
| 6 | TMO | Thermo Fisher Scientific | 3.80% |
| 7 | AMGN | Amgen | 3.76% |
| 8 | GILD | Gilead Sciences | 3.15% |
| 9 | ABT | Abbott Laboratories | 2.91% |
| 10 | PFE | Pfizer | 2.55% |
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsMedical - DistributionMedical - Care FacilitiesDrug Manufacturers - SpecialtySoftware - ApplicationMedical - SpecialtiesOther
SPDR XLV · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 78.9%
All XLV Holdings
64 holdings · as of Nov 5, 2026XLV
XLV’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly + | Healthcare | 16.50% | $1,650.38 | 6.0M | $8.45B |
| 2 | JNJJohnson + Johnson | Healthcare | 9.69% | $968.61 | 17.9M | $4.96B |
| 3 | ABBVAbbvie | Healthcare | 7.58% | $757.84 | 13.2M | $3.88B |
| 4 | MRKMerck + | Healthcare | 5.40% | $539.60 | 18.4M | $2.76B |
| 5 | UNHUnitedhealth Group | Healthcare | 5.34% | $534.50 | 6.7M | $2.74B |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.80% | $379.79 | 2.8M | $1.94B |
| 7 | AMGNAmgen | Healthcare | 3.76% | $376.28 | 4.0M | $1.93B |
| 8 | GILDGilead Sciences | Healthcare | 3.15% | $314.69 | 9.2M | $1.61B |
| 9 | ABTAbbott Laboratories | Healthcare | 2.91% | $290.74 | 12.9M | $1.49B |
| 10 | PFEPfizer | Healthcare | 2.55% | $255.27 | 42.4M | $1.31B |
| 11 | ISRGIntuitive Surgical | Healthcare | 2.48% | $247.74 | 2.6M | $1.27B |
| 12 | DHRDanaher | Healthcare | 2.14% | $213.80 | 4.7M | $1.09B |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 2.02% | $202.42 | 1.9M | $1.04B |
| 14 | BMYBristol Myers Squibb | Healthcare | 1.91% | $190.73 | 15.2M | $976.3M |
| 15 | MDTMedtronic | Healthcare | 1.87% | $186.89 | 9.1M | $956.7M |
SPDR XLV · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 5, 2026
How It Compares
XLV
State Street Health Care Select Sector SPDR ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put XLV head to head with VHT →VHT vs XLV
YTDYear to date
XLV wins+1.2 pts
Past year
XLV wins+1.5 pts
Fee
XLV winslower fee
Yield
Level
AUM
XLV2.7× more
3–0XLV wins
Vanguard VHT and SPDR XLV · year-to-date · as of Nov 6, 2026 · AUM not scored
XLV vs VOO
YTDXLV · Health Care Select Sector SPDR
+20.9%
VOO · S&P 500
+8.4%
Gap
12.5 pts
SPDR XLV and Vanguard VOO · YTD total return · as of Nov 6, 2026
XLV vs Its Peer Average
YTDXLVAvsBPeer average
1D−2.5%−3.4%
1M+9.5%+4.6%
3M+12.0%+3.5%
YTD+20.9%+19.7%
1Y+29.6%+29.0%
3Y+56.1%+75.3%
5Y+51.3%+27.3%
6–1XLV wins
38 Health care peers · each row scaled to its leader
The Details
XLV
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y16.84%
Deepest drop · 1Y−10.5%
Lowest point · 5Y−8.9%
52-week range
$184.91
$141.97−3.8% from the high$192.31
SPDR XLV · past-year price moves · as of Nov 6, 2026
XLV
Fund Facts
Today1998launched Dec 16
Tracks[…]
Exchange · CUSIPAMEX · 81369Y209
StructureETF
Leverage1x
Cost on $10,000$8 a year
Go deeper
SPDR XLV · fund facts · as of Nov 6, 2026
XLV
Payouts by Year
13Y$0.64per share, Sep 2026
Distribution yield1.4%
PaidEvery quarter
Latest ex-date · paidSep 21 · Sep 23, 2026
12 payouts added up$7.26 a share
SPDR XLV · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-06-30 ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-06-30 ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗SEC reported portfolio · 2024-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-09-30 ↗SEC reported portfolio · 2023-06-30 ↗SEC reported portfolio · 2023-03-31 ↗SEC reported portfolio · 2022-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-06-30 ↗SEC reported portfolio · 2022-03-31 ↗SEC reported portfolio · 2021-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-09-30 ↗SEC reported portfolio · 2021-06-30 ↗SEC reported portfolio · 2021-03-31 ↗SEC reported portfolio · 2020-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-09-30 ↗SEC reported portfolio · 2020-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2019-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2019-09-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$189.65
Premium / discount[…]
Median spread · 30D[…]
Volume today23.9M
Average volume · 30D10.1M
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.08%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$8.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.64 |
| Jun 22, 2026 | Jun 24, 2026 | $0.66 |
| Mar 23, 2026 | Mar 25, 2026 | $0.59 |
| Dec 22, 2025 | Dec 24, 2025 | $0.66 |
| Sep 22, 2025 | Sep 24, 2025 | $0.62 |
| Jun 23, 2025 | Jun 25, 2025 | $0.63 |
| Mar 24, 2025 | Mar 26, 2025 | $0.56 |
| Dec 23, 2024 | Dec 26, 2024 | $0.62 |
| Sep 23, 2024 | Sep 25, 2024 | $0.58 |
| Jun 24, 2024 | Jun 26, 2024 | $0.57 |
| Mar 18, 2024 | Mar 21, 2024 | $0.52 |
| Dec 18, 2023 | Dec 21, 2023 | $0.60 |
Issuer contentFrom SPDRHear the strategy from the people behind XLV.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →